Skip to main content
KRYS logo

KRYS · Krystal Biotech, Inc. · Holdings

Track KRYS — free
Market Cap
$9.15B
Shares
29.63M
Volume · Nov 20 286.86K Avg daily vol (3M) 285.9K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 447
Total Value: $9,645,681,826
Total Shares: 29,004,675
+ 259,030 shares withheld under SEC confidential treatment, last reported; not in the totals
Showing 1–100 of 466 holdings by value · page 1 of 5

Institutional Ownership Trend

27 quarters

A holder reported that quarter and withheld its positions under SEC confidential treatment, which is not a sale. The line counts it at the shares it last reported; filers usually disclose the real figures about a year later.

Holder Concentration

Share of 13F common-share value, across 447 filers with any position, options included · Δ vs Jun 30, 2026
Top Holder
15.3%
Dec 2023 → Sep 2026 · range 10.5% – 16.8%
+0.4 pts
Top 5
47.0%
Dec 2023 → Sep 2026 · range 44.8% – 54.5%
−1.7 pts
Top 10
62.8%
Dec 2023 → Sep 2026 · range 61.6% – 68.6%
−0.5 pts
HHI
613
Dec 2023 → Sep 2026 · range 509 – 731
Broadly held−31

Who Holds KRYS

Last 8 quarters through Sep 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Sep 30, 2026: 442 filers, like-for-like change -3.3%; actively managed books +0.2%; index-like books -3.5%.

Holder type Share Filers Change
Registered adviser 42.6% 242 -6.8%
Exempt adviser 0.0% 2 +6340.8%
Adviser 6.5% 13 +8.2%
Bank 8.9% 20 +6.8%
Insurer 0.5% 3 -33.2%
Broker-dealer 0.0% 2 +168.0%
Benefit plan 0.2% 8 +10.7%
Non-US 1.4% 11 -27.7%
Holding company 30.7% 12 -5.1%
Unknown 9.1% 129 +12.9%
How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 4 holders with no observed 2026-06-30 13F and 11 holders with no observed 2026-09-30 13F.

Conviction and Crowding

442 13F filers, quarter ended Sep 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
9
2.04% of filers hold it in their top 10
Jun 30, 2026: 12
Holders above 5%
5
median weight 0.007%
Jun 30, 2026: 7
Crowding
30.8%
of shares outstanding, 81st percentile
Private-fund advisers
26.7%
of shares outstanding
Institutional ownership
98.0%
109.9% of the estimated free float above 100%: filers can report lent or client shares more than once
Top 10 holders
62.8%
of 13F shares, Herfindahl 0.061
Active holders
+0.2%
like-for-like share change of active filers
5% stakes on record
4
0 13D, 4 13G (3 institutional, 0 passive, 1 exempt)
How long holders have held it value-weighted 17.7 quarters
Under 1 year 13.3% 1 to 3 years 22.7% 3 years or more 64.0% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $11,419,181 (11 buying, 13 selling).

Estimated Holder Cost Basis

Quarter ended Sep 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$181.38
estimated per share
Jun 30, 2026: $161.85
Quarter-end price
$332.56
implied by 13F values
Estimated gain or loss
+83.3%
price against the estimated cost
Estimated at a loss
5.40%
of costed 13F value

Estimated cost covers 38.7% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies KRYS's active holders also own, quarter ended Sep 30, 2026
# Company Shared holders
1 KNSA Kiniksa Pharmaceuticals International, plc 11
2 GKOS GLAUKOS Corp 12
3 CHEF Chefs' Warehouse, Inc. 8
4 AXSM Axsome Therapeutics, Inc. 12
5 CLDX Celldex Therapeutics, Inc. 9
6 TGTX Tg Therapeutics, Inc. 11
7 PVLA Palvella Therapeutics, Inc. 7
8 KYMR Kymera Therapeutics, Inc. 9
9 ARWR Arrowhead Pharmaceuticals, Inc. 10
10 NRIX Nurix Therapeutics, Inc. 8

Shareholder Targets

13F filers that own its peers but not KRYS, quarter ended Sep 30, 2026

Found through its holder-overlap peers: KNSA, GKOS, CHEF, AXSM, CLDX, TGTX, PVLA, KYMR, ARWR, NRIX, SNDX, TWST, LXEO, MBX, YARW, INSM, EWTX, BEAM, NBIX, ASND. 1,120 filers in all.

# Filer In peers
1 T. Rowe Price Investment Management, Inc. Adviser, Diversified active $2,816,381,641 5 held
2 RA CAPITAL MANAGEMENT, L.P. Registered adviser, Concentrated $2,700,078,071 3 held
3 BAKER BROS. ADVISORS LP Registered adviser, Concentrated $2,639,006,708 7 held
4 Artisan Partners Limited Partnership Registered adviser, Diversified active $1,670,612,096 7 held
5 Capital International Investors Adviser, Diversified active $1,390,433,265 2 held
6 Vestal Point Capital, LP Registered adviser, Concentrated $1,337,920,350 7 held
7 D. E. Shaw & Co., Inc. Unknown, Systematic-like $1,289,951,255 17 held
8 ARK Investment Management LLC Registered adviser, Diversified active $989,206,716 3 held
9 Paradigm Biocapital Advisors LP Registered adviser, Concentrated $966,499,131 3 held
10 Driehaus Capital Management LLC Registered adviser, Diversified active $834,353,343 12 held

Fund Ownership of KRYS by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 28.28% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 4.27% 1,265,221
Index ETFs 24.01% 7,115,636
Active ETFs 0.97% 287,355
Active funds 20.27% 6,007,208
Unclassified 0.11% 31,551
All registered funds 49.63% 14,706,971
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Quarterly Activity

vs Jun 30, 2026
New
76
Increased
181
Decreased
123
Sold Out
52
Unchanged
63

New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.

Holder count: +17
Institutional value: -12.3%
Shares held: -4.3%

Institutional value and shares held compare the totals as filed: 259,030 shares reported for Jun 30, 2026 by holders that withheld this quarter are left out, and that part of the change is not a sale.

Top Buyers

vs Jun 30, 2026
Institution Added Now Holds Open

Top Sellers

vs Jun 30, 2026
Institution Sold Now Holds Open

Top New Positions

vs Jun 30, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Jun 30, 2026
Institution Previously Held Last Value (USD) Open
Showing 100 of 466
Export CSV
Holder Value (USD) % of 13F Shares Own % Change Type Filed Open

Showing the top 100 of 466 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1711279 CUSIP 501147102 13F (30d) 434 filings 402 filers Visit website Investor relations